Both are effective, FDA-approved medications for opioid use disorder — the right choice depends on your specific situation more than on one being “better” than the other in general.
Where methadone tends to fit better
- Higher opioid tolerance or more severe opioid use disorder, where methadone’s full-agonist effect may provide more complete symptom control
- Situations where the daily structure of OTP visits (at least initially) provides valuable stability and support
- People who haven’t responded as well to buprenorphine previously
Where buprenorphine tends to fit better
- Wanting to avoid daily clinic visits, especially after the initial stabilization period
- Access to a regular doctor or telehealth provider rather than a specialized OTP, especially in areas without a nearby clinic
- A preference for a partial-agonist medication’s different risk and side effect profile
Practical factors that often decide it
- Location — OTPs are less geographically available than buprenorphine prescribers in many areas
- Schedule — daily OTP visits (even if only for a period) versus buprenorphine’s more flexible dispensing options
- Prior treatment history — what has or hasn’t worked before is often the most practically useful piece of information
- Cost and insurance — worth comparing directly [link to cost estimator tool]
This isn’t necessarily a permanent, one-time choice
Switching between methadone and buprenorphine is possible, though it requires careful medical management given how differently they interact with opioid receptors. "switching from methadone to buprenorphine" article
Use our comparison tool
[MAT comparison tool] walks through this alongside naltrexone, filtered by what matters most to you — work schedule, travel, pregnancy, or starting requirements.
Medically reviewed by [pending]. Sources: SAMHSA TIP 63, ASAM National Practice Guideline.